Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSExternal comparators (ECs) built from real world data (RWD), and the resulting real world evidence (RWE), are increasingly being applied to support initial regulatory approval and labeling changes for marketed products.
Join us for this webinar where we will discuss recommendations from the FDA draft guidance and success factors for getting ECs right in oncology.
Key Topics:
Leanne Li, MPH, MBA
Sr. Principal, Real World Strategy and Innovation, U.S. Real World Solutions, IQVIA
Mayank Raizada, MS
Principal, Regulatory Science & Strategy, IQVIA
David Alsadius, MD, PhD
Sr. Medical Director, Medical Strategy Lead for Oncology, IQVIA
Mohsin Shah, MBBS, MSCE
Consultant Epidemiologist, Epidemiology and Drug Safety, U.S. Real World Solutions, IQVIA